CRISPR THERAPEUTICS AG
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 15.7% | 15.7% | 13.7% |
| FY2022 | -34.7% | -34.7% | -29.0% |
| FY2023 | -8.2% | -8.2% | -6.9% |
| FY2024 | -19.0% | -19.0% | -16.3% |
| FY2025 | -30.3% | -30.3% | -25.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 15.7% | 15.7% | 13.7% |
| FY2022 | -34.7% | -34.7% | -29.0% |
| FY2023 | -8.2% | -8.2% | -6.9% |
| FY2024 | -19.0% | -19.0% | -16.3% |
| FY2025 | -30.3% | -30.3% | -25.7% |